drugset / Trial / NCT02637310
Evaluate the Efficacy and Safety of N02RS1 in Patient With Acute Bronchitis
RandomizedParallel-groupDouble-blindTreatment
Summary
A multi center, randomized, double-blind, placebo-controlled, parallel, phase 2b clinical trial to evaluate the efficacy and safety of N02RS1 in patients with acute bronchitis
Timeline
- Start
- 2015-12
- Primary completion
- 2016-03
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | N02RS1 | Unknown | 1200 mg | Oral |